3De Leo V, Ditto A, la Marca A, et al. Bone mineral density and biomarker of hone turnover in peri-and postmenopausal women. Calcif Tissue Int, 2000,66(4) :263-267.
4Collaborative group on hormonal factor in breast cancer. Breast cancer and HRT: Collaborative reanalysis of data from 51 epidenioloqical studies of 52705 women with breast cancer and 108411 women without breast cancer. Lancet, 1997,350:1047-1059.
5Cooper C, Wickham C, Walsh K. Appendicular skeletal status and hipfracture in the elderly: 14-year pros pective data. Bone, 1991,12:161-364.
6Karakoc B, Erenus M .Compliance considerations with hormone replacement therapy. Menopause, 1998 , 5(2): 102-106.
7Elliott ME, Meek PD, Kanous NL,et al.Pharmacy-based bone mass measurement to assess osteoporosis risk. Ann Pharmacother, 2002 , 36(4): 571-577.
8Silverman SL, Greenwald M, Klein RA,et al.Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol, 1997 , 89(3): 321-325 .
9Sedlak CA ,Doheny MO, Jones SL. Osteoporosis prevention in young women. Orthop Nurs. 1998, 17(3):53-56.
10Juby AG,Davis P. A prospective evaluation of the awareness, knowledge, risk factors and current treatment of osteoporosis in a cohort of elderly subjects. Osteoporos Int, 2001, 12(8): 617-622 .
